A carregar...
Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting
A promising strategy in cancer immunotherapy is the employment of a bispecific agent that can bind with both tumor markers and immunocytes for recruitment of lymphocytes to tumor sites and enhancement of anticancer immune reactions. Mucin1 (MUC1) is a tumor marker overexpressed in almost all adenoca...
Na minha lista:
| Publicado no: | Molecules |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6385031/ https://ncbi.nlm.nih.gov/pubmed/30699986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24030478 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|